996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 54
◽
pp. S479-S480
◽
Keyword(s):
2012 ◽
Vol 20
(2)
◽
pp. 150-155
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 99
(9)
◽
pp. 1733-1737
◽
2007 ◽
Vol 102
(10)
◽
pp. 2181-2188
◽
Keyword(s):
Keyword(s):